Grapheal has received an award for its graphene-enabled products at CES 2022.
Graphene Flagship Associated Member Grapheal has won the “Best in Innovation” Award from the Consumer Electronics Show (CES), considered the world’s most influential technology event. “We’re thrilled to receive this honor,” says Vincent Bochiat, CEO and co-founder of Grapheal. The company develops graphene-enabled technologies for the healthcare and medtech sectors.
The CES “Best in Innovation” Award recognized Grapheal’s TestNPass technology, a stand-alone test strip to detect biomarkers and deliver a time-stamped, encrypted RFID tag. In this case, graphene provides outstanding sensitivity within the test digital biosensor. “We exploit graphene’s uniquely high sensitivity to detect biomolecules at a low level, without need for amplification,” explains Bouchiat.
Since the device is simultaneously coupled with a free smartphone app through NFC, the test results become immediately available on your digital device, quicker than traditional COVID passports. To protect the users’ privacy, TestNPass uses secure biometric identifiers and encrypted RFID technology. “Our health pass is read and interpreted without sharing any personal information online,” explains Bouchiat.
Kari Hjelt, Head of Innovation of the Graphene Flagship, highlights: “This award demonstrates the high-market potential of graphene-enabled products. Grapheal is a valued Associated Member of our project, funded by the European Commission to bring graphene and layered materials to the market. The CES tradeshow and awards are incredibly prestigious, usually awarded to multi-billion companies like Sony, Apple, Abbott… We’re absolutely elated they decided to recognize Grapheal and graphene this year.”